PLoS ONE (Jan 2011)

Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.

  • Gro Askgaard,
  • Ulrik Sloth Kristoffersen,
  • Jesper Mehlsen,
  • Gitte Kronborg,
  • Andreas Kjaer,
  • Anne-Mette Lebech

DOI
https://doi.org/10.1371/journal.pone.0020196
Journal volume & issue
Vol. 6, no. 5
p. e20196

Abstract

Read online

UnlabelledThe presence of autonomic dysfunction in HIV patients is largely unknown. Early studies found autonomic dysfunction in patients with AIDS. Antiretroviral combination therapy (ART) has dramatically changed the course of the disease and improved prognosis and decreased morbidity.AimTo evaluate whether autonomic dysfunction is present in an ART treated HIV population and if so to identify factors of importance.MethodsHIV patients receiving ART for at least 12 months (n = 97) and an age-matched control group of healthy volunteers (n = 52) were included. All were non-diabetic and had never received medication for hypertension. Following a 10 min resting period a 15 min ECG recording was performed. Heart-rate variability (HRV) analysis was performed in accordance with current guidelines and data reported as mean [interquartile range].ResultsMean normal-to-normal (NN) and total HRV measured as standard deviation of normal-to-normal (SDNN) was lower in HIV patients compared to controls (905 vs. 982 ms; pConclusionsModerate autonomic dysfunction is present in HIV positives patients even with suppressed viral load due to ART. The dysfunction is correlated with HbA1c and hypercholesterolemia but not to duration of HIV or whether the patients were receiving protease inhibitors as part of the ART regime.